Does Ozempic Cause Constipation? An Endocrinologist Explains

Gastrointestinal side effects are among the most frequently reported issues with Ozempic (semaglutide), a GLP-1 receptor agonist widely prescribed for type 2 diabetes and weight management. Constipation, in particular, affects a significant portion of patients, often leading to discomfort and questions about long-term tolerability. As an endocrinologist, I frequently counsel patients on why Ozempic causes constipation, how common it is, and—most importantly—how to manage it effectively without discontinuing therapy.

Why Does Ozempic Cause Constipation?

Ozempic (semaglutide) mimics the action of glucagon-like peptide-1 (GLP-1), a hormone that regulates blood sugar, appetite, and gastrointestinal motility. While GLP-1 enhances insulin secretion and slows gastric emptying, it also reduces intestinal transit speed—meaning food moves more slowly through the digestive tract. This delay allows for greater water absorption in the colon, leading to harder, drier stools and constipation.

A 2021 study published in Diabetes Care analyzed pooled data from the SUSTAIN clinical trials and found that semaglutide slowed colonic transit time by approximately 30% compared to placebo. This mechanism is dose-dependent and explains why Ozempic side effects like constipation often emerge early in treatment. Additionally, semaglutide reduces appetite, which can lead to lower fiber and fluid intake—two key factors that worsen constipation.

Clinically, this effect is not unique to Ozempic; other GLP-1 receptor agonists (e.g., liraglutide, dulaglutide) also report constipation as a common adverse event. However, the potency and longer half-life of semaglutide may contribute to a higher incidence.

How Common Is Constipation on Ozempic?

Constipation is one of the most prevalent gastrointestinal Ozempic side effects, with clinical trial data providing clear estimates. In the SUSTAIN program, which evaluated Ozempic for type 2 diabetes, constipation was reported in 11–15% of patients receiving semaglutide 0.5 mg or 1 mg weekly, compared to 3–4% in the placebo group. In the STEP trials for weight management, constipation occurred in 24–30% of participants using semaglutide 2.4 mg, the dose approved as Wegovy.

Real-world data from the FDA Adverse Event Reporting System (FAERS) corroborates these findings, with constipation ranking among the top five reported side effects of Ozempic. A 2023 analysis in JAMA Network Open found that gastrointestinal events, including constipation, were the leading cause of treatment discontinuation in GLP-1 users, though most cases were mild to moderate.

Risk factors for constipation on Ozempic include older age, female sex, low baseline fiber intake, and pre-existing gastrointestinal motility disorders. Patients with a history of irritable bowel syndrome (IBS) or chronic constipation may experience more pronounced symptoms.

How Long Does Ozempic Constipation Last?

The duration of constipation on Ozempic varies, but most patients experience symptoms within the first 4–8 weeks of treatment. This timeline aligns with the drug’s gradual dose escalation (e.g., starting at 0.25 mg weekly) and the body’s adaptation to semaglutide’s effects on gut motility.

A post-hoc analysis of the SUSTAIN trials, published in Clinical Therapeutics, showed that constipation incidence peaked during the first 12 weeks of Ozempic therapy and declined thereafter. By week 26, only 5–7% of patients still reported constipation, suggesting tolerance develops over time. However, for some individuals, symptoms may persist for several months, particularly if dietary or lifestyle adjustments are not made.

In clinical practice, I advise patients that constipation on Ozempic is often transient but may require proactive management. If symptoms continue beyond 3–4 months without improvement, reassessment of contributing factors (e.g., hydration, fiber intake, or concomitant medications) is warranted.

How to Manage Constipation While Taking Ozempic

Managing constipation on Ozempic requires a multifaceted approach targeting hydration, diet, and physical activity. First, increasing fluid intake to at least 2–3 liters per day helps soften stools and counteract the dehydrating effects of semaglutide. Fiber intake should be gradually increased to 25–35 grams daily, focusing on soluble fiber sources like oats, beans, and psyllium husk, which add bulk without excessive gas.

Over-the-counter (OTC) options can provide relief. Osmotic laxatives such as polyethylene glycol (Miralax) are first-line choices, as they are gentle and non-habit-forming. Stimulant laxatives (e.g., senna or bisacodyl) may be used short-term but are not recommended for chronic use due to the risk of dependence. Probiotics, particularly strains like Bifidobacterium lactis, have shown modest benefit in improving bowel regularity in patients on GLP-1 therapy, per a 2022 study in Nutrients.

Lifestyle modifications are equally critical. Regular physical activity, even light walking, stimulates intestinal motility. Establishing a consistent bowel routine—such as attempting a bowel movement after meals—can leverage the gastrocolic reflex. For patients struggling with appetite suppression from Ozempic, small, frequent meals with high-fiber snacks (e.g., nuts, fruits) can help maintain caloric and fiber intake.

When to See Your Doctor About Ozempic and Constipation

While constipation on Ozempic is often manageable, certain red flags warrant medical evaluation. Patients should seek care if constipation is accompanied by severe abdominal pain, bloating, vomiting, or inability to pass gas, as these may indicate bowel obstruction—a rare but serious complication. Other concerning symptoms include blood in the stool, unexplained weight loss, or constipation lasting longer than 3–4 weeks despite interventions.

In such cases, your doctor may order diagnostic tests, such as abdominal X-rays or colon transit studies, to rule out structural or functional gastrointestinal disorders. For patients with pre-existing conditions like diverticulosis or a history of bowel surgery, Ozempic may exacerbate constipation and require closer monitoring.

If constipation significantly impacts quality of life or persists despite conservative measures, your provider may consider adjusting the Ozempic dose, switching to an alternative GLP-1 receptor agonist, or adding a prescription medication like lubiprostone or linaclotide. However, Ozempic should not be discontinued abruptly without medical guidance, as this can lead to rebound hyperglycemia or weight regain.

Ozempic Constipation vs Other GLP-1 Side Effects

Constipation is just one of several gastrointestinal Ozempic side effects linked to its mechanism of action. Compared to other GLP-1-related adverse events, constipation is less immediately distressing than nausea or vomiting but can be more persistent. In the SUSTAIN trials, nausea occurred in 15–20% of patients but typically resolved within 4–8 weeks, whereas constipation often lingered longer.

Other common side effects include diarrhea (reported in 5–8% of patients), abdominal pain (6–9%), and dyspepsia (4–7%). These symptoms are thought to result from semaglutide’s effects on gastric emptying and intestinal motility. Interestingly, some patients experience alternating constipation and diarrhea, which may reflect underlying irritable bowel syndrome (IBS) or individual variability in gut response to GLP-1 agonists.

A 2023 meta-analysis in The Lancet Diabetes & Endocrinology compared gastrointestinal side effects across GLP-1 receptor agonists and found that semaglutide had a higher incidence of constipation than liraglutide or exenatide but a lower rate of nausea. This profile suggests that while Ozempic is highly effective for glycemic control and weight loss, its gastrointestinal tolerability may vary based on individual patient factors.

Does Ozempic Dosage Affect Constipation?

The risk and severity of constipation on Ozempic are dose-dependent. In clinical trials, higher doses of semaglutide were associated with increased rates of constipation. For example, in the STEP 1 trial, constipation occurred in 24% of patients on semaglutide 2.4 mg (Wegovy) versus 11% on the 1 mg dose (Ozempic). This trend reflects the greater suppression of gastrointestinal motility at higher GLP-1 receptor occupancy.

The dose-escalation protocol for Ozempic (starting at 0.25 mg weekly and titrating to 0.5 mg or 1 mg) is designed to minimize side effects, including constipation. However, even at lower doses, some patients may experience symptoms. A 2022 study in Diabetes, Obesity and Metabolism found that constipation severity correlated with semaglutide plasma concentrations, suggesting that individual pharmacokinetics play a role.

For patients who develop constipation at lower doses, clinicians may slow the titration schedule or temporarily reduce the dose before resuming escalation. Conversely, patients tolerating Ozempic well at 1 mg may not experience worsening constipation if switched to higher doses for weight management. Close monitoring and patient education are key to balancing efficacy and tolerability.

Frequently Asked Questions

Does Ozempic cause constipation in everyone?

No, Ozempic does not cause constipation in all users. While it is a common side effect, affecting 11–30% of patients depending on dose, many individuals tolerate the medication without gastrointestinal issues. Factors like diet, hydration, and baseline gut motility influence susceptibility.

How long does constipation last on Ozempic?

Constipation on Ozempic typically peaks within the first 4–12 weeks of treatment and often improves as the body adapts. Most patients see resolution within 3–6 months, though some may experience persistent symptoms if dietary or lifestyle adjustments are not made.

Can you prevent constipation on Ozempic?

Yes, constipation on Ozempic can often be prevented or minimized. Strategies include increasing fiber and fluid intake, staying physically active, and using prophylactic osmotic laxatives like polyethylene glycol. Starting with a low dose and titrating slowly may also reduce the risk.

Is constipation a reason to stop taking Ozempic?

Constipation alone is rarely a reason to discontinue Ozempic. Most cases are mild to moderate and can be managed with dietary changes and OTC medications. However, if constipation is severe, persistent, or accompanied by concerning symptoms, consult your doctor to discuss dose adjustments or alternative therapies.

Disclaimer from Dr. Nina Patel: The information provided in this article is for educational purposes only and does not substitute for professional medical advice. Always consult your healthcare provider before making changes to your medication regimen or managing side effects.